We are live on
!
Find out more
KA
Kerrisdale Advisers Portfolio holdings
AUM
$399M
1-Year Est. Return
42.87%
This Fund
S&P 500
This Quarter
Est. Return
+15.02%
1 Year Est. Return
+42.87%
3 Year Est. Return
+78.79%
5 Year Est. Return
+40.49%
10 Year Est. Return
+1,155.21%
AUM
$102M
AUM Growth
-$139M
(-58%)
Cap. Flow
-$187M
Cap. Flow
% of AUM
-183.13%
Top 10 Holdings %
Top 10 Hldgs %
95.62%
Holding
16
New
2
Increased
2
Reduced
4
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HUYA
Huya Inc
HUYA
|
+$8.05M |
| 2 |
EA
Electronic Arts
EA
|
+$7.56M |
| 3 |
Sea Limited
SE
|
+$1.44M |
| 4 |
MOMO
Hello Group
MOMO
|
+$175K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
I
INTELSAT S. A.
I
|
+$170M |
| 2 |
LXFT
Luxoft Holding, Inc.
LXFT
|
+$18.2M |
| 3 |
Expedia Group
EXPE
|
+$12.3M |
| 4 |
PTC Therapeutics
PTCT
|
+$1.35M |
| 5 |
REGI
Renewable Energy Group, Inc.
REGI
|
+$886K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 58.81% |
| 2 | Technology | 31.71% |
| 3 | Real Estate | 3.44% |
| 4 | Consumer Discretionary | 2.94% |
| 5 | Healthcare | 2.11% |
Similar funds
BCM
LIP
FSA
TBWA
VBFP
VWM
SC
AA
Kerrisdale Advisers's Q3 2018 Portfolio in Review
As of Q3 2018, Kerrisdale Advisers held 16 positions worth $102M, down 58% from $241M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Kerrisdale Advisers withdrew a net $187M in Q3 2018, closing 2 positions and reducing 4 holdings. Its most notable exit was PTC Therapeutics, an estimated $1.35M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 59% of assets, down from 73% a quarter earlier, followed by Technology and Real Estate.
Against the trend, Kerrisdale Advisers opened a new position in Electronic Arts worth $7.07M.
- Kerrisdale Advisers's largest Q3 2018 buy was Electronic Arts: 58,650 shares worth $7.07M.
- Kerrisdale Advisers added most to Huya Inc in Q3 2018, an estimated $8.05M increase.
- Kerrisdale Advisers's biggest Q3 2018 reduction was INTELSAT S. A., cutting an estimated $170M.
- Kerrisdale Advisers fully exited PTC Therapeutics in Q3 2018, selling an estimated $1.35M.
- Kerrisdale Advisers's ten largest holdings make up 96% of its $102M portfolio in Q3 2018.
- Kerrisdale Advisers opened 2 new positions and closed 2 in Q3 2018.
- Kerrisdale Advisers's portfolio value fell 58% quarter-over-quarter to $102M.
Based on Kerrisdale Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.